Clinical Trials Sponsored by Egalet Ltd

Total 16937 results

Egalet Ltd

Completed

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects

Healthy Subjects

United Kingdom
Egalet Ltd

Completed

Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine

Assess Pharmacokinetics of Ketorolac Tromethamine Intranasal and Assess Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine

United Kingdom
Egalet Ltd

Completed

A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery

Pain | Dental Impaction

United States
Egalet Ltd

Completed

Single Dose Pharmacokinetics of Egalet® Oxycodone

Pain

Canada
Egalet Ltd

Completed

Single Dose Pharmacokinetics of Egalet® Hydrocodone

Pain

Canada
Egalet Ltd

Completed

Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain

Moderate-to-severe Chronic Low Back Pain

United States
Egalet Ltd

Completed

SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures

Pain

Poland
Egalet Ltd

Completed

Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers

Healthy Volunteers

United Kingdom
Egalet Ltd

Completed

Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers

Healthy Volunteers

United Kingdom
Egalet Ltd

Completed

Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

Allergic Rhinitis

Australia
Egalet Ltd

Completed

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

Moderate-to-severe Chronic Noncancer Pain

United States
Egalet Ltd

Completed

The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years

Postoperative Pain

United States
Egalet Ltd

Completed

Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers

Healthy Volunteers

United Kingdom
Egalet Ltd

Completed

Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device

Healthy Subjects

United Kingdom
Egalet Ltd

Completed

Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery

Postoperative Pain

United States, New Zealand
Egalet Ltd

Completed

Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain

Postoperative Pain

New Zealand
Egalet Ltd

Completed

Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

Migraine

Germany
Egalet Ltd

Completed

Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers

Pain
Egalet Ltd

Terminated

A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Hypertension

Denmark
Egalet Ltd

Completed

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Pain | Cancer

Lithuania, Poland
Emalex Biosciences Inc.
Syneos Health; Cambridge Cognition Ltd

Recruiting

Drug Interaction Study

Drug Interaction

Canada
Emalex Biosciences Inc.

Recruiting

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Tourette Syndrome

United States, Canada
Emalex Biosciences Inc.

Recruiting

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults (D1AMOND)

Tourette Disorder

United States, Canada, Spain, Poland, Italy, Bulgaria, Denmark, France, Germany, Hungary, Serbia, Romania
Emalex Biosciences Inc.

Completed

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents (D1AMOND)

Tourette Syndrome

United States, Poland, France, Canada, Germany
Galen Limited

Completed

Bioequivalence Study of Co-codamol 15mg/500mg Capsules vs Co-codamol 30mg/500mg Tablets in Healthy Subjects

Healthy

United Kingdom
Emalex Biosciences Inc.

Completed

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (D1AMOND)

Tourette Syndrome in Children | Tourette Syndrome in Adolescence

United States, Poland, France, Canada, Germany
Emalex Biosciences Inc.
Covance

Completed

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Healthy Volunteer

United Kingdom
Galen Limited

Completed

Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects

Healthy

United Kingdom
Eagle Pharmaceuticals, Inc.

Terminated

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Drug Toxicity Psychotropic Agents Psychostimulants

United States
Eagle Pharmaceuticals, Inc.

Completed

A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients

Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate

United States
Phoenix Eagle Company

Suspended

Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers

Pressure Ulcer | Venous Ulcer

Australia
Emalex Biosciences Inc.
Psyadon Pharma

Terminated

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Lesch-Nyhan Disease | Self-injurious Behavior

Spain, United States
Université Victor Segalen Bordeaux 2

Completed

Tracheal Dosage of Amylase : a New Surrogate for Microaspirations in Ventilated ICU Patients

Ventilated-acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Completed

Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful? (REAMICHOC)

Acute Kidney Injury | Severe Sepsis

France
Emalex Biosciences Inc.
Psyadon Pharma

Completed

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Healthy

United States
Emalex Biosciences Inc.
Psyadon Pharma

Completed

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Tourette's Syndrome

United States
Université Victor Segalen Bordeaux 2

Completed

E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis.

Hospital-acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Completed

Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia

Ventilator Acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Suspended

Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria

Malaria

Cameroon
Eagle Pharmaceuticals, Inc.

Recruiting

Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia

Pneumonia, Bacterial

Spain, United States, France, Latvia, Romania, Chile, Argentina, Greece, South Africa, Georgia, Brazil, Czechia, Hungary, Colombia, Peru, Serbia
Eagle Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration

Pharmacokinetics

United States
Eagle Pharmaceuticals, Inc.

Completed

Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS

Exertional Heat Stroke

Saudi Arabia
Emalex Biosciences Inc.
PPD; Clario

Completed

Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

QT/QTc

United States
Emalex Biosciences Inc.
Syneos Health; Nuventra

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

Drug Interaction

United States
Centre d'Expertise sur l'Altitude EXALT

Active, not recruiting

Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World (RINCOVID)

Covid19 | High Altitude

Peru
Eagle Vision Pharmaceutical Corp.

Completed

Safety and Efficacy of SeeMore (TM) in Heart Patients

Myocardial Infarction
Egret Medical Products Inc.

Completed

Study the Average Aerobic Bioburden Levels on Catheters After Use With Egret Catheter and the Predicate Device

Suction Catheter Bioburder Level After Patient Use.

United States
Centre d'Expertise sur l'Altitude EXALT

Unknown

Treatment of Chronic Mountain Sickness (Exp5300)

Hypoxia, Altitude

France
Centre d'Expertise sur l'Altitude EXALT

Completed

Hypnotic Intake and Motor and Cognitive Performances at High Altitude (CHAM)

Physiology

France
Emalex Biosciences Inc.
Syneos Health; Nuventra

Terminated

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

Drug-Interactions

United States

3

Subscribe